ArticleJournal of clinical pharmacology2025
Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication.
Nimish Vakil et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.